Aspen Pharmacare reported ZAR10.14B in Gross Profit on Sales for its fiscal semester ending in June of 2024.


Gross Profit On Sales Change Date
Adcock Ingram Holdings ZAR 1.54B 73.26M Dec/2024
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 45.34B 66.3M Jun/2025
Dr.Reddys Laboratories INR 48.63B 8.16B Jun/2025
Jiangsu Hengrui CNY 7.51B 1.43B Jun/2025
Kalbe Farma IDR 3.3T 49.99B Jun/2025
Life Healthcare 5.11B 1.04B Sep/2024
Netcare ZAR 6.5B 546M Sep/2024
Richter Gedeon HUF 147.67B 5.55B Sep/2024